Prothena Corporation plc announced the publication of Phase 2 clinical trial data for coramitug (formerly PRX004), a potential first-in-class amyloid depleter antibody, for the treatment of ATTR ...

Circle reported financial results for the third quarter on Wednesday. The transcript from the earnings call has been provided below.

Your eyes—retinal blood vessels and retinal imaging—may help predict heart disease, according to a new study. Here, doctors ...

As your sun-kissed glow gives way to crisp winter air, your skin may start to feel the effects of cooler, drier weather. Yet, ...